Skip to main content
Log in

Ein „zu früh“ gibt es nicht

Hautkrebs rechtzeitig erkennen

  • FORTBILDUNG_SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

2008 wurde in Deutschland die weltweit erste landesweite Früherkennungsuntersuchung für Hauttumoren eingeführt. Dazu gehört neben dem wachen klinischen Blick auf die Haut Ihrer Patienten die konsequente Ganzkörperinspektion sowie die Identifizierung von Risikopatienten. Anhand von Fallbeispielen will der Beitrag Sie für dieses wichtige Thema sensibilisieren.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Gesellschaft der epidemiologischen Krebs-register in Deutschland e.V. Atlas der Krebsinzidenz und -mortalität in Deutschland (GEKID-Atlas). Datenlieferung: Dezember 2012, Lübeck, 2013. http://www.gekid. de (Zugriff 24.11.2013)

  2. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol. 2012; 166 (5):1069–80

    Article  CAS  Google Scholar 

  3. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. 2003;149(6):1200–6

    Article  CAS  Google Scholar 

  4. Rogers HW, Coldiron BM. Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008. Dermatol Surg. 2013;39(1 Pt 1):35–42

    Article  CAS  Google Scholar 

  5. Krebs in Deutschland 2007/2008. 8. Ausgabe. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Berlin, 2012

  6. Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW. Effectiveness of skin cancer screening programmes. Br J Dermatol. 2012;167 Suppl 2:94–8

    Article  Google Scholar 

  7. Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. E.Cancer. 2012;118(21):5395–402

    Article  Google Scholar 

  8. Kittler H, Pehamberger H, Wolff K, Binder M. Diagnostic accuracy of dermoscopy. Lancet Oncol. 2002;(3):159–65.

  9. Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D. Malignant melanoma S3-guideline „diagnosis, therapy and follow-up of melanoma“. J Dtsch Dermatol Ges. 2013;11 Suppl 6:1–116, 1-126

    PubMed  Google Scholar 

  10. Tsao H, Chin L, Garraway LA, Fisher DE. Melanoma: from mutations to medicine. Genes Dev. 2012;26(11):1131–1155

    Article  CAS  Google Scholar 

  11. Gorlin RJ, Goltz RW. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome.N Engl J Med. 1960;262:908–12

    Article  CAS  Google Scholar 

  12. DiGiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Invest Dermatol. 2012 Mar;132(3 Pt 2):785–96

    Article  CAS  Google Scholar 

  13. Breuninger H, Eigentler T, Bootz F, Hauschild A, Kortmann RD, Wolff K, Stockfleth E, Szeimies RM, Rompel R, Garbe C, Grabbe S. Brief S2k guidelines-Cutaneous squamous cell carcinoma. J Dtsch Dermatol Ges. 2013;11 Suppl 3:37–45, 39-47

    Article  Google Scholar 

  14. Hofbauer GF, Bouwes Bavinck JN, Euvrard S. Organ transplantation and skin cancer: basic problems and new perspectives. Exp Dermatol. 2010;19(6):473–82

    Article  Google Scholar 

  15. Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res. 2002;160:251–8

    Article  CAS  Google Scholar 

  16. Stockfleth E, Terhorst D, Hauschild A, Zouboulis CC, Schlaeger M, Oster-Schmidt C, Diepgen T, Garbe C, Gollnick H, Korting C, Merk H, Sterry W, Kerl H, Berking C. [Actinic keratoses]. J Dtsch Dermatol Ges. 2012 Dec;10 Suppl 7:S1–23

    Article  Google Scholar 

  17. Schrama D, Ugurel S, Becker JC. Merkel cell carcinoma: recent insights and new treatment options. Curr Opin Oncol. 2012,24(2):141–9

    Article  Google Scholar 

  18. Hauschild A, Breuninger H, Kaufmann R, Kortmann RD, Klein M, Werner J, Reifenberger J, Dirschka T, Garbe C. Brief S2k guidelines-Basal cell carcinoma of the skin. J Dtsch Dermatol Ges. 2013;11 Suppl 3:10–5, 11-6

    Article  Google Scholar 

  19. Schmitt J, Seidler A, Diepgen TL, Bauer A. Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis. Br J Dermatol. 2011;164(2):291–307

    Article  CAS  Google Scholar 

  20. Elsner P, Blome O, Diepgen TL. UV-induced occupational skin cancer: possibilities of secondary individual prevention in the „Dermatologist’s Procedure“. J Dtsch Dermatol Ges. 2013;11(7):625–30

    PubMed  Google Scholar 

  21. Gemeinsames Ministerialblatt 64. Jahrgang, Nr. 35, ISSN 0939-4729

  22. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, Mc-Masters KM, Mihm MC Jr, Morton DL, Ross MI, Sober AJ, Sondak VK. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206

    Article  Google Scholar 

  23. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC. Distinct sets of genetic alterations in melanoma. N Engl J Med. 2005;353(20):2135–47

    Article  CAS  Google Scholar 

  24. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA. Source. Mutations of the BRAF gene in human cancer. 2002;417(6892):949–54

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicolai Treiber.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Treiber, N., Huber, M.A., Scharffetter-Kochanek, K. et al. Ein „zu früh“ gibt es nicht. MMW - Fortschritte der Medizin 156, 37–41 (2014). https://doi.org/10.1007/s15006-014-2718-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-2718-2

Keywords - Early detection of skin cancer

Navigation